These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19383369)

  • 1. Ebselen abrogates TNFalpha induced pro-inflammatory response in glioblastoma.
    Tewari R; Sharma V; Koul N; Ghosh A; Joseph C; Hossain Sk U; Sen E
    Mol Oncol; 2009 Feb; 3(1):77-83. PubMed ID: 19383369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex.
    Sharma V; Tewari R; Sk UH; Joseph C; Sen E
    Int J Cancer; 2008 Nov; 123(9):2204-12. PubMed ID: 18709644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Ebselen on polymorphonuclear leukocyte adhesion to and migration through cytokine-activated vascular endothelium.
    Issekutz AC; Lopes N
    Int J Immunopharmacol; 1992 Nov; 14(8):1383-90. PubMed ID: 1464470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebselen and cytokine-induced nitric oxide synthase expression in insulin-producing cells.
    de-Mello MA; Flodström M; Eizirik DL
    Biochem Pharmacol; 1996 Dec; 52(11):1703-9. PubMed ID: 8986132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury.
    Tiegs G; Küsters S; Künstle G; Hentze H; Kiemer AK; Wendel A
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1098-104. PubMed ID: 9864298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells.
    Yoshizumi M; Fujita Y; Izawa Y; Suzaki Y; Kyaw M; Ali N; Tsuchiya K; Kagami S; Yano S; Sone S; Tamaki T
    Exp Cell Res; 2004 Jan; 292(1):1-10. PubMed ID: 14720501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of ebselen on neutrophil recruitment, chemokine, and inflammatory mediator expression in a rat model of lipopolysaccharide-induced pulmonary inflammation.
    Haddad el-B; McCluskie K; Birrell MA; Dabrowski D; Pecoraro M; Underwood S; Chen B; De Sanctis GT; Webber SE; Foster ML; Belvisi MG
    J Immunol; 2002 Jul; 169(2):974-82. PubMed ID: 12097404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenoorganic compound, ebselen, inhibits nitric oxide and tumor necrosis factor-alpha production by the modulation of jun-N-terminal kinase and the NF-kappab signaling pathway in rat Kupffer cells.
    Shimohashi N; Nakamuta M; Uchimura K; Sugimoto R; Iwamoto H; Enjoji M; Nawata H
    J Cell Biochem; 2000 Jun; 78(4):595-606. PubMed ID: 10861857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
    Pratta MA; Ackerman NR; Arner EC
    Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ebselen on polymorphonuclear leukocyte migration to joints in rats with adjuvant arthritis.
    Gao JX; Issekutz AC
    Int J Immunopharmacol; 1993 Oct; 15(7):793-802. PubMed ID: 8262693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebselen suppresses inflammation induced by Helicobacter pylori lipopolysaccharide via the p38 mitogen-activated protein kinase signaling pathway.
    Xu L; Gong C; Li G; Wei J; Wang T; Meng W; Shi M; Wang Y
    Mol Med Rep; 2018 May; 17(5):6847-6851. PubMed ID: 29488609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ebselen on polymorphonuclear leukocyte and lymphocyte migration to inflammatory reactions in rats.
    Gao JX; Issekutz AC
    Immunopharmacology; 1993; 25(3):239-51. PubMed ID: 8354640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ebselen--an in vivo immune response modifier.
    Wendel A; Kuesters S; Tiegs G
    Biomed Environ Sci; 1997 Sep; 10(2-3):253-9. PubMed ID: 9315318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of hippocampal chemical-induced injury response by ebselen, pentoxifylline, and TNFalpha-, IL-1alpha-, and IL-6-neutralizing antibodies.
    Jean Harry G; Bruccoleri A; Lefebvre d'Hellencourt C
    J Neurosci Res; 2003 Aug; 73(4):526-36. PubMed ID: 12898537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebselen: prospective therapy for cerebral ischaemia.
    Parnham M; Sies H
    Expert Opin Investig Drugs; 2000 Mar; 9(3):607-19. PubMed ID: 11060699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina.
    Tan SM; Deliyanti D; Figgett WA; Talia DM; de Haan JB; Wilkinson-Berka JL
    Exp Eye Res; 2015 Jul; 136():1-8. PubMed ID: 25912997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of inhibition of zinc-finger transcription factors by selenium compounds ebselen and selenite.
    Larabee JL; Hocker JR; Hanas JS
    J Inorg Biochem; 2009 Mar; 103(3):419-26. PubMed ID: 19167089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo.
    Baek JM; Kim JY; Yoon KH; Oh J; Lee MS
    Int J Biol Sci; 2016; 12(5):478-88. PubMed ID: 27019631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory properties of ebselen in a model of sephadex-induced lung inflammation.
    Belvisi MG; Haddad EB; Battram C; Birrell M; Foster M; Webber S
    Eur Respir J; 2000 Mar; 15(3):579-81. PubMed ID: 10759456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selenoorganic compound ebselen suppresses liver injury induced by Propionibacterium acnes and lipopolysaccharide in rats.
    Koyanagi T; Nakamuta M; Enjoji M; Iwamoto H; Motomura K; Sakai H; Nawata H
    Int J Mol Med; 2001 Mar; 7(3):321-7. PubMed ID: 11179515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.